检索结果 - Changhoon Yoo

Refine Results
  1. 1
    Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor

    Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor 由 Changhoon Yoo, Dok Hyun Yoon, Cheolwon Suh

    出版 2014
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Recent Advances in Systemic Therapy for Advanced Intrahepatic Cholangiocarcinoma

    Recent Advances in Systemic Therapy for Advanced Intrahepatic Cholangiocarcinoma 由 Changhoon Yoo, Jaewon Hyung, Stephen L. Chan

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors

    Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors 由 Changhoon Yoo, Min‐Hee Ryu, Jungmin Jo, Inkeun Park, Baek‐Yeol Ryoo, Yoon‐Koo Kang

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis

    Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker an... 由 Changhoon Yoo, Min‐Hee Ryu, Young-Soon Na, Baek‐Yeol Ryoo, Chae-Won Lee, Yoon‐Koo Kang

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients

    Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients 由 Bum Jun Kim, Changhoon Yoo, Kyu‐pyo Kim, Jaewon Hyung, Seongjoon Park, Baek‐Yeol Ryoo, Heung-Moon Chang

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen

    Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen 由 Changhoon Yoo, Bum Jun Kim, Kyu‐pyo Kim, Jae‐Lyun Lee, Tae Won Kim, Baek‐Yeol Ryoo, Heung-Moon Chang

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab–bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan

    Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab–bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospec... 由 Jaekyung Cheon, Shigeo Shimose, Hyung‐Don Kim, Takashi Niizeki, Min‐Hee Ryu, Tomotake Shirono, Baek‐Yeol Ryoo, Hideki Iwamoto, Changhoon Yoo

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma

    Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma 由 Changhoon Yoo, JiHoon Kang, Ho Yeong Lim, Jee Hyun Kim, Myung Ah Lee, Kyung-Hun Lee, Tae‐You Kim, Baek‐Yeol Ryoo

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors

    Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors 由 Changhoon Yoo, Ángela Lamarca, Hye Jin Choi, Arndt Vogel, Michael J. Pishvaian, Lipika Goyal, Makoto Ueno, Angela Märten, Michael Teufel, Lijiang Geng, Chigusa Morizane

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors

    Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors 由 Joo Young Kim, Jisup Kim, Yong-il Kim, Dong‐Hoon Yang, Changhoon Yoo, In Ja Park, Baek‐Yeol Ryoo, Jin‐Sook Ryu, Seung‐Mo Hong

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer

    Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer 由 Changhoon Yoo, Do-Youn Oh, Hye Jin Choi, Masatoshi Kudo, Makoto Ueno, Shunsuke Kondo, Li-Tzong Chen, Motonobu Osada, Christoph Helwig, Isabelle Dussault, Masafumi Ikeda

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Multicenter retrospective analysis of the safety and efficacy of regorafenib after progression on sorafenib in Korean patients with hepatocellular carcinoma

    Multicenter retrospective analysis of the safety and efficacy of regorafenib after progression on sorafenib in Korean patients with hepatocellular carcinoma 由 Changhoon Yoo, Joong‐Won Park, Yoon Jun Kim, Do Young Kim, Su Jong Yu, Tae Seop Lim, Su Jin Lee, Baek‐Yeol Ryoo, Ho Yeong Lim

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis

    Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis 由 Jaekyung Cheon, Hong Jae Chon, Yeonghak Bang, Neung Hwa Park, Jung Woo Shin, Kang Mo Kim, Han Chu Lee, Joo‐Ho Lee, Changhoon Yoo, Baek‐Yeol Ryoo

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib

    Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib 由 Y-K. Kang, Changhoon Yoo, B-Y. Ryoo, J J Lee, Eugene Tan, Inkeun Park, J H Park, Yoon Ji Choi, Jungmin Jo, J.-S. Ryu, M.H. Ryu

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial

    Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, pha... 由 Yoon‐Koo Kang, Min‐Hee Ryu, Changhoon Yoo, Baek‐Yeol Ryoo, Hyun Jin Kim, Jong Jin Lee, Byung‐Ho Nam, Nikhil H. Ramaiya, Jyothi P. Jagannathan, George D. Demetri

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Effectiveness and Safety of Nivolumab in Child–Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study

    Effectiveness and Safety of Nivolumab in Child–Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study 由 Won‐Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Changhoon Yoo, Sook Ryun Park, Min‐Hee Ryu, Baek‐Yeol Ryoo, Jonggi Choi

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer

    A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer 由 Changhoon Yoo, Jenn-Jiang Hwang, Je Hyeong Kim, T W Kim, J S Lee, D H Park, S S Lee, Dong Wan Seo, S K Lee, MH Kim, Dongjin Han, Sung‐Cheol Kim, Jia-Lin Lee

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy

    CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy 由 Hyung‐seung Jin, Minkyung Ko, Dasom Choi, June Hyuck Kim, Dong-Hee Lee, Seong-Ho Kang, Inki Kim, Hee Jin Lee, Eun Kyung Choi, Kyu‐pyo Kim, Changhoon Yoo, Yoon Park

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    <i>Chlamydia psittaci</i> infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea

    <i>Chlamydia psittaci</i> infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea 由 Changhoon Yoo, Min‐Hee Ryu, Jooryung Huh, Ji Hyun Park, Hye Jin Kang, Hyo Sook Ahn, Yongjae Lee, Myoung Joon Kim, Hyoungnam Lee, Tae Won Kim, Heung Moon Chang, Jae‐Lyun Lee, Yoon‐Koo Kang

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials

    Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials 由 Changhoon Yoo, Anna Saborowski, Jaewon Hyung, Patrick Wenzel, Il Hwan Kim, Henning Wege, Kyu‐pyo Kim, Gunnar Folprecht, Baek‐Yeol Ryoo, Phillip Schütt, Jaekyung Cheon, Thorsten Oliver Goetze, Hyewon Ryu, Ji Sung Lee, Arndt Vogel

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: